Guojin Group
Overview
Guojin Group is a Chinese private investment firm specializing in various sectors, including healthcare and biopharmaceuticals. The firm is headquartered in Yangzhou, Jiangsu Province, and operates across multiple industries, such as technology, consumer goods, energy, real estate, financial services, manufacturing, media, telecommunications, retail, transportation, education, agriculture, and automotive. The firm's investment strategy encompasses early-stage, growth, late-stage, pre-IPO, and buyout investments, with a focus on private equity, venture capital, real estate, and financial services. Guojin Group primarily operates within China, targeting a wide range of industries to diversify its portfolio. Guojin Group has made several investments, including a notable Series C funding round in Novlead Biotech on April 15, 2025. The firm's investment approach aims to drive economic growth and provide robust financial support to various sectors, contributing to the development of China's economy.
Investment Focus
- Strong growth potential
- Innovative business models
- Experienced management teams
- Scalable operations
- Competitive market positioning
Portfolio Companies
Reach Guojin Group directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Guojin Group
What sectors does Guojin Group invest in?
Guojin Group invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in Jiangsu, China. Guojin Group is listed as a private investment firm in the ConnectSafely investor database.
What stage does Guojin Group invest at?
Guojin Group backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 1M - 50M.
Which regions does Guojin Group invest in?
Guojin Group invests across China.
What companies has Guojin Group invested in?
Guojin Group's portfolio includes Novlead Biotech.
Last updated · Source: ConnectSafely investor database
